Grunenthal

AstraZeneca sells rights to cholesterol drug Crestor to Grunenthal

https://pharmaphorum.com/news/astrazeneca-sells-rights-to-cholesterol-drug-crestor-to-grunenthal/

How COVID-19 is changing the sales model

https://pharmaphorum.com/views-analysis-sales-marketing/covid-19-changing-sales-model/

Mundipharma, Grünenthal accused of kickbacks in Italy

https://pharmaphorum.com/news/mundipharma-grunenthal-italy-opioid/

Grünenthal buys certain rights to AZ’s Nexium and Vimovo for $922m

https://pharmaphorum.com/news/grunenthal-buys-certain-rights-to-azs-nexium-and-vimovo-for-922m/

AZ considers options as US gout drug deal backfires

https://pharmaphorum.com/news/az-considers-options-drug-deal-backfires/

AZ sells migraine drug rights to Grunenthal for $300m

https://pharmaphorum.com/news/az-sells-zomig-300m/

Five UK pharma companies “named and shamed” by watchdog

https://pharmaphorum.com/news/five-pharmas-named-shamed-pmcpa/

EU regulator begins publishing detailed study data

https://pharmaphorum.com/news/eu-regulator-begins-publishing-study-data/

AZ sells US, EU and Latin America rights to gout drug

https://pharmaphorum.com/news/az-sells-us-eu-and-latin-america-rights-to-gout-drug/

Close in 10 seconds

Pharmaphorum.com

Search